Dive into the World of Neurology Every Sunday!

Get ready to flex your mental muscles with NeurologyLive® Brain Games, a thrilling weekly quiz series that kicks off every Sunday morning! Each edition is packed with questions crafted by leading physicians and experts in neurology, covering everything from clinical practices to historical breakthroughs in the field.

This is your chance to test your knowledge on a diverse range of topics, including dementia, Alzheimer’s disease, epilepsy, migraines, movement disorders, multiple sclerosis, and more. Each week, you can expect three thought-provoking questions designed to challenge and expand your understanding of neurological health.

This Week's Focus: RNA Therapeutics!

This week's quiz spotlights the fascinating theme of RNA therapeutics for neuromuscular disorders. Can you keep up with the cutting-edge developments in treatment?

Sample Questions to Sharpen Your Skills!

Here’s a sneak peek at what’s in store: Which RNA therapeutic was the first antisense oligonucleotide approved for Duchenne muscular dystrophy (DMD)? Your options are:

- Risdiplam - Eteplirsen - Nusinersen - Golodirsen

Can you also identify what action Risdiplam, approved for spinal muscular atrophy (SMA), is known for? Here’s a hint: it enhances SMN2 exon 7 inclusion!

Unlock the Mysteries of Myotonic Dystrophy!

In the case of myotonic dystrophy type 1 (DM1), RNA-targeted therapies focus on reducing expanded CTG repeats in the DMPK gene. Can you guess what else these advanced therapies aim to combat?

Join the Fun and Challenge Yourself!

Think you have what it takes? Join us this Sunday for your chance to prove your expertise and engage with fellow neurology enthusiasts. Plus, if you're interested in contributing your own quiz questions, reach out to our editor, Marco Meglio, at [email protected]. Challenge your mind and make a difference in the field!